跳至主要内容
临床试验/KCT0002238
KCT0002238招募中未知

Efficacy and Safety of ATEon reducing body weight and body fat of overweight subjects; A 12week, Randomized, Double-blind, Placebo-Controlled Clinical Trial

Dong Il Pharmtec0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 60(Year)(—)
性别
All

入选标准

  • 1)Subject who voluntarily agree to participate and signs informed consent form
  • 2) 20 years= Age = 60years)
  • 3) 25kg/m^2= BMI =29.9kg/m^2

排除标准

  • 1) Subjects with severe cerebrovascular disease, cardiac disease (If that patient's clinical status is stable, they can participate in the clinical trial according to investgator) within recent 6 months
  • 2) Subjects for uncontrolled hypertension(systolicBP = 160 mmHg or diastolicBP = 100 mmHg)
  • 3) Subjects with diabetes(use of hypoglycemic agent or insulin)or fasting blood glucose = 126 mg/dL or random blood glucose = 200 mg/dL
  • 4) Subjects with TSH(thyroid-stimulating hormone) = 0.1 uIU/ml or = 15 uIU/ml
  • 5) Subjects with Creatinine = 2 times the upper limit of normal
  • 6) Subjects with AST or ALP = 3 times the upper limit of normal
  • 7) Subjects with complaint of severe gastrointestinal symptoms such as heartburn, dyspepsia
  • 8) Subjects who take the medicine that can affect the state of weight change (uptake inhibitors, appetite suppressant, health functional food for diet, antidepressants, ß- blocker, diuretics, contraceptives, steroid, and female sex hormone) within recent 1 months
  • 9) Participation in commercial diet program within the 3 months prior to screening
  • 10) Participation in any clinical trial within the 1 month prior to screening or have a plan to participate in other clinical trial
  • 11) Subjects who get hospitalization, medications or rehabilitation treatments for Alcohol disorders, cardiovascular disease, disorder of central nervous system
  • 12) Subjects with the musculoskeletal disorders or restricted physical activity
  • 13) Women who are pregnant of lactating or planning to pregnant
  • 14) Subjects which in the opinion investigator could affect preclude evaluation of response

研究者

发起方
Dong Il Pharmtec

相似试验